Survey On Switching Immunoglobulin Products (IG)
by Lauren
Posted on May 8, 2018
IPOPI are seeking the input of patients living with primary immunodeficiency and parents who are taking care of a child with a primary immunodeficiency (under the age of 18 years), using IG replacement therapy who have switched to another brand or mode of administration (intravenous, subcutaneous, facilitated subcutaneous) during the last 2 years.
The survey is available for replies on Survey Monkey
